ACTRN12617000691347已完成未知
The Melanoma Genomics Managing Your Risk Study: a randomised controlled trial of the efficacy of personal melanoma genomic risk of information, compared to standard prevention advice, in motivating reduced exposure to ultraviolet radiation in the general population
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,025
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 69 Years（—）
- 性别
- All
入选标准
- •People from the general population aged 18-69 years with European ancestry, who have never had a melanoma (since this study is primarily aimed at prevention), and have sufficient English to complete the study questionnaires.
排除标准
- •Outside the eligible age range, personal history of melanoma, no European ancestry, insufficient English to complete the study questionnaires
研究者
相似试验
已完成
不适用
Melanoma prevention in Australian primary care patientsMelanoma preventionPublic Health - Health promotion/educationCancer - Malignant melanomaACTRN12615001019594Sydney School of Public Health, Sydney Medical School, University of Sydney265
Unknown
不适用
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic ImplicationsMelanomaNCT05119829Hellenic Cooperative Oncology Group80
已完成
不适用
The MAGPIE Study: Multi-cancer genomic risk assessment to target screening in general practiceBowel CancerBreast CancerProstate CancerBreast cancer screeningBowel cancer screeningProstate cancer screeningSkin cancer screeningCancer - BreastCancer - Malignant melanomaCancer - ProstateCancer - Bowel - Back passage (rectum) or large bowel (colon)MelanomaACTRN12623000053628niversity of Melbourne149
招募中
不适用
ung Cancer Genomic Screening Project for Individualized Medicine Molecular Testing for Resistant Tumors to Systemic Therapyon-small cell lung cancerJPRN-UMIN000041957ational Cancer Center Hospital East10,000
已完成
不适用
ung Cancer Genomic Screening Project for Individualized Medicine in JapaJPRN-UMIN000010234ational Cancer Center Hospital East6,500